InDex Pharmaceuticals
Stockholm
About InDex Pharmaceuticals
InDex Pharmaceuticals AB is a clinical stage biopharmaceutical company building a leading immunotherapy franchise based on its TLR platform (toll-like receptors). It discovers and develops DIMS drugs (DNA-based immunomodulatory sequence) to treat diseases within a variety of therapeutic areas, including inflammation and cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $31.9M
- Last round: Grant (Mar 2020)
- Website: indexpharma.comen
- Phone: 46 8 50 88 47 30
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/index-pharmaceuticals-191370 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.